.png "Untitled(29)")
When
May 12, 2026
09:00am & 05:00pm CEST
Where
The Zoom link will be sent by email upon registration
Info
Trace impurities in biologic and peptide drugs can activate the innate immune system and lead to unwanted immunogenicity. Assessing this risk is becoming increasingly important, with regulatory agencies placing greater emphasis on impurity testing.
In this joint webinar, Mabtech and IQVIA Laboratories present how EYRAplex has been qualified as a multiplex cytokine readout platform for the detection of innate immune response modulating impurities (IIRMI).
What you will learn
- The role of trace impurities in triggering innate immune responses
- Key considerations for IIRMI testing in biologics and peptide drugs
- How multiplex cytokine analysis supports immunogenicity assessment
- The qualification of EYRAplex for sensitive and reliable detection
- How EYRA and EYRAplex can support your impurity testing workflows
The presentation will take approximately 45 minutes and will be followed by a live Q&A session. You are welcome to submit your questions in advance or during the webinar.
Speakers
Berend Bassleer holds a Master of Science in Molecular Biology. He joined Mabtech in 2022 as Account Manager for Benelux and France and was appointed Product Manager for Instruments in 2024.
Séverine Giltaire holds a PhD in Pharmaceutical and Biomedical Sciences. As Senior Scientist and Team Lead of the Custom In Vitro Solutions department at IQVIA Laboratories In Vitro Immunology, she has over 10 years of experience in the development and execution of immunological cell‑based assays. She also brings extensive expertise in multiplex cytokine analysis technologies, supporting tailored in vitro strategies for preclinical and translational projects.
Sofie Denies holds a Master’s degree in Statistics and a PhD in Immuno-Oncology. As a biostatistician at IQVIA Laboratories, she has over 8 years of experience supporting the qualification of cell-based assays and preclinical immunogenicity evaluations. She has also been an invited speaker at international conferences on the analysis of preclinical immunological assays.